Comparison of broccoli sprout extracts in non-pregnant and pregnant women
Comparing broccoli sprout supplement formulations for circulating sulforaphane concentration in non-pregnant and pregnant women
Monash Health
56 participants
Jul 26, 2023
Interventional
Conditions
Summary
Sulforaphane is a naturally occurring organophosphur able to upregulate phase II detoxification enzymes resulting in anti-inflammatory and antioxidant effects. Sulforaphane has been widely investigated outside of pregnancy in a wide variety of clinical trials including cancer, autism spectrum disorder and gastroesophageal reflux disease. Sulforaphane is generally administered in the form of glucurophanin via broccoli sprout supplements and has variable formulations and manufacturing pathways. It is hypothesised that sulforaphane will provide beneficial effects to various pathological states of pregnancy. It is important to compare the various formulations of sulforaphane commercially available to inform decisions for clinical trial design and analysis of sulforaphane trial outcomes. This study will compare three different commerically available broccoli sprout extracts and their circulating concentrations in healthy pregnant participants.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Three different commercially available broccoli sprout extracts will be compared for their circulating concentration of sulforaphane. Participants will be enrolled into groups sequentially until allocation exhausted. Participants will be allocated to group 1 first, group 2 second and group 3 third. Each participant provided a single dose from one of the three different extracts Group 1 - two capsules (total dose - 500mg) stabilized sulforaphane formulation BROQ - total sulforaphane dose 26.1mg Group 2 - two capsules (1400mg) broccoli sprout supplement GeneActiv Formulation E by Cell-Logic - total sulforaphane dose 21mg Group 3 - four capsules (1760g) broccoli sprout supplement AVMACOL® Regular Strength - total sulforaphane dose 21.8mg
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12623000592640